Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 45 (12), 1568-1576

Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article


Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article

Somaye Yosaee et al. Iran J Public Health.


Background: Heart disease is one of the most common chronic disease and leading cause of morbidity and mortality worldwide. Adropin, a newly identified protein, is important for energy homeostasis and maintaining insulin sensitivity, and has been referred to as a novel regulator of endothelial cells. Endothelial dysfunction is a key early event in atherogenesis and onset of HD. Therefore, this review gives a systematic overview of studies investigating plasma adropin level in patient with heart disease.

Methods: Data carried out in PubMed, Scopus, Web of Science, Embase, Google scholar and MEDLINE, from the earliest available online indexing year through 2015. The search restricted to studies conducted in humans. The keyword search was adropin to apply in title, abstract and keywords. References lists of all original published articles were scanned to find additional eligible studies.

Results: Heart failure (HF), coronary atherosclerosis acute myocardial infarction and Cardiac Syndrome X (CSX) were type of heart disease acknowledged in this study. Majority of evidences introduced low adropin as an independent risk factor of heart disease. In a case-control study, the plasma level of adropin increased with the severity of HF.

Conclusion: Adropinmay be a potential serum biomarker for early diagnosis of HD.

Keywords: Adropin; Endothelium; Heart; Systematic review.

Similar articles

See all similar articles

Cited by 3 PubMed Central articles


    1. Fuster V, Kovacic JC. (2014). Acute Coronary Syndromes Pathology, Diagnosis, Genetics, Prevention, and Treatment. Circ Res, 114( 12): 1847–51. - PMC - PubMed
    1. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. (2000). Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med, 342( 16): 1163–70. - PubMed
    1. Swap CJ, Nagurney JT. (2005). Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. JAMA, 294( 20): 2623–9. - PubMed
    1. Vasan RS. (2006). Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation, 113( 19): 2335–62. - PubMed
    1. Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, et al. (2008). Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab, 8( 6): 468–81. - PMC - PubMed

LinkOut - more resources